November 5, 2015
Sanofi and Hanmi in $3.5B license agreement (developing diabetes treatments)
Sanofi and Hanmi Pharmaceutical Co., Ltd. announced Thursday a worldwide license agreement to develop a portfolio of experimental, long-acting diabetes treatments.